Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 29, 2020

SELL
$121.19 - $165.49 $3.39 Million - $4.63 Million
-28,000 Closed
0 $0
Q2 2020

Jul 22, 2020

SELL
$104.21 - $156.44 $62,525 - $93,864
-600 Reduced 2.1%
28,000 $4.15 Million
Q1 2020

Apr 22, 2020

BUY
$93.12 - $133.99 $46,560 - $66,995
500 Added 1.78%
28,600 $3.11 Million
Q4 2019

Feb 03, 2020

BUY
$74.51 - $124.23 $2.09 Million - $3.49 Million
28,100 New
28,100 $3.24 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Railway Pension Investments LTD Portfolio

Follow Railway Pension Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Railway Pension Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Railway Pension Investments LTD with notifications on news.